{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:48:33Z","timestamp":1794512913725,"version":"4.9.1"},"reference-count":36,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>BK virus\u2013associated cystitis\/urethritis (BK-C) is a major cause of morbidity in allogeneic hematopoietic cell transplant (HCT) recipients. We prospectively followed weekly plasma and urine BK viral loads and associated symptoms in 169 recipients of posttransplant cyclophosphamide (PTCy)-based HCT. Patients with \u22652 positive BK specimens before day +100 were considered at-risk for developing BK-C. Many patients had detectable BK viruria already before the start of conditioning (40%) and HCT (51%), whereas baseline detectable BK viremia was less common (8% and 11%, respectively). Of 169 patients, 133 (79%) were at risk for BK-C: of these, 96 (72%) developed BK-C after a median 30 days after HCT, which lasted a median 26 days; 76 (79%) had macroscopic hematuria. BK viral levels measured in the first post-HCT month had high prognostic value for subsequent occurrence of BK-C. At time of onset, 96% and 80% had BK viruria \u22657 and \u22659 log10 IU\/mL, respectively. In univariate analyses, BK-C was associated with male sex, marrow grafts, sirolimus, and myeloablative conditioning (MAC); earlier BK-C onset was associated with high-dose (compared with intermediate- or low-dose) PTCy, BK positivity at HCT, reduced-intensity conditioning (RIC), and underlying immune deficiency. Busulfan use, cyclophosphamide dosing, RIC, and underlying immune deficiency were associated with prolonged symptom duration. In recipients of MAC, PTCy dosing also correlated with symptom duration. Our study confirms a very high rate of BK-C after PTCy-based HCT; lower PTCy dose may shorten BK-C duration in specific patient subsets. Early post-HCT monitoring of BK viruria may help identify patients who will subsequently develop BK-C.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016589","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T14:56:06Z","timestamp":1756306566000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["BK virus kinetics and associated cystitis\/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4868-6852","authenticated-orcid":false,"given":"Dimana","family":"Dimitrova","sequence":"first","affiliation":[{"name":"1Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Xue","sequence":"additional","affiliation":[{"name":"1Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7597-2646","authenticated-orcid":false,"given":"Mustafa A.","family":"Hyder","sequence":"additional","affiliation":[{"name":"1Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoyoung","family":"Choo-Wosoba","sequence":"additional","affiliation":[{"name":"2Office of Collaborative Biostatistics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Rechache","sequence":"additional","affiliation":[{"name":"1Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3422-606X","authenticated-orcid":false,"given":"Francis A.","family":"Flomerfelt","sequence":"additional","affiliation":[{"name":"3Clinical Research Correlatives Core, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2246-7942","authenticated-orcid":false,"given":"Sanchita","family":"Das","sequence":"additional","affiliation":[{"name":"4Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christi","family":"McKeown","sequence":"additional","affiliation":[{"name":"5Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Cusmano","sequence":"additional","affiliation":[{"name":"1Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Sabina","sequence":"additional","affiliation":[{"name":"1Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9522-3618","authenticated-orcid":false,"given":"Jennifer A.","family":"Kanakry","sequence":"additional","affiliation":[{"name":"1Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7736-2056","authenticated-orcid":false,"given":"Christopher G.","family":"Kanakry","sequence":"additional","affiliation":[{"name":"1Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"1","key":"2026011308563834500_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","article-title":"Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40","volume":"71","author":"Knowles","year":"2003","journal-title":"J Med Virol"},{"issue":"2","key":"2026011308563834500_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/CMR.00074-16","article-title":"BK polyomavirus: clinical aspects, immune regulation, and emerging therapies","volume":"30","author":"Ambalathingal","year":"2017","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"2026011308563834500_bib3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","article-title":"Polyomavirus BK","volume":"3","author":"Hirsch","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2026011308563834500_bib4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/bloodadvances.2019000802","article-title":"Presentation of BK polyomavirus-associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation","volume":"4","author":"Imlay","year":"2020","journal-title":"Blood Adv"},{"issue":"11","key":"2026011308563834500_bib5","doi-asserted-by":"crossref","first-page":"e15121","DOI":"10.1111\/ctr.15121","article-title":"Risk factors for BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"37","author":"Zhou","year":"2023","journal-title":"Clin Transplant"},{"issue":"5","key":"2026011308563834500_bib6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1200\/JCO.1995.13.5.1103","article-title":"Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation","volume":"13","author":"Bedi","year":"1995","journal-title":"J Clin Oncol"},{"issue":"4","key":"2026011308563834500_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"20","author":"Jodele","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2026011308563834500_bib8","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/bloodadvances.2021004933","article-title":"Acute BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults","volume":"6","author":"Vasu","year":"2022","journal-title":"Blood Adv"},{"issue":"11","key":"2026011308563834500_bib10","first-page":"875","article-title":"Risk assessment for BK virus-associated hemorrhagic cystitis after pediatric hematopoietic stem cell transplant: a single-center retrospective cross-sectional study","volume":"22","author":"Karagun","year":"2024","journal-title":"Exp Clin Transplant"},{"issue":"1","key":"2026011308563834500_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/bmt.2016.193","article-title":"The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide","volume":"52","author":"Rimondo","year":"2017","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"2026011308563834500_bib9","doi-asserted-by":"crossref","first-page":"e13601","DOI":"10.1111\/tid.13601","article-title":"Risk factors of BK viral hemorrhagic cystitis in allogenic hematopoietic stem cell transplantation","volume":"23","author":"Kaphan","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"2026011308563834500_bib12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bbmt.2018.12.142","article-title":"Higher incidence of hemorrhagic cystitis following haploidentical related donor transplantation compared with matched related donor transplantation","volume":"25","author":"Copelan","year":"2019","journal-title":"Biol Blood Marrow Tr"},{"issue":"3","key":"2026011308563834500_bib13","doi-asserted-by":"crossref","first-page":"182.e1","DOI":"10.1016\/j.jtct.2024.12.006","article-title":"Incidence, risk factors, and outcomes of BK hemorrhagic cystitis in hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplant cyclophosphamide","volume":"31","author":"Chorao","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"2026011308563834500_bib14","doi-asserted-by":"crossref","first-page":"48.e1","DOI":"10.1016\/j.jtct.2021.09.015","article-title":"Post-transplantation cyclophosphamide is associated with an increase in non-cytomegalovirus herpesvirus infections in patients with acute leukemia and myelodysplastic syndrome","volume":"28","author":"Singh","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"23","key":"2026011308563834500_bib15","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1182\/blood.2020009362","article-title":"Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis","volume":"137","author":"Goldsmith","year":"2021","journal-title":"Blood"},{"issue":"1","key":"2026011308563834500_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/bjh.17563","article-title":"Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation","volume":"194","author":"Mulroney","year":"2021","journal-title":"Br J Haematol"},{"issue":"4","key":"2026011308563834500_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41409-022-01908-y","article-title":"Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies","volume":"58","author":"Dul\u00e9ry","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2026011308563834500_bib18","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1182\/bloodadvances.2024014879","article-title":"Intermediate-dose post-transplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation","volume":"9","author":"Hyder","year":"2025","journal-title":"Blood Adv"},{"issue":"1","key":"2026011308563834500_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbmt.2019.08.018","article-title":"Prospective study of a novel, radiation-free, reduced-intensity bone marrow transplantation platform for primary immunodeficiency diseases","volume":"26","author":"Dimitrova","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"2026011308563834500_bib20","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/s41409-022-01819-y","article-title":"Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning","volume":"57","author":"Dimitrova","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2026011308563834500_bib21","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2026011308563834500_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2026011308563834500_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/pbc.24679","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the childhood cancer survivor study","volume":"61","author":"Green","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2026011308563834500_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"issue":"8","key":"2026011308563834500_bib25","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41409-022-01665-y","article-title":"Incidence, risk factors and outcome of BK virus hemorrhagic cystitis following allogenic hematopoietic cell transplantation: a retrospective cohort study","volume":"57","author":"Saade","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"2026011308563834500_bib26","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1093\/cid\/ciz1194","article-title":"The natural history of BK polyomavirus and the host immune response after stem cell transplantation","volume":"71","author":"Laskin","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2026011308563834500_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/cid\/cix804","article-title":"Kinetics of double-stranded DNA viremia after allogeneic hematopoietic cell transplantation","volume":"66","author":"Hill","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"16","key":"2026011308563834500_bib28","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2016-10-748426","article-title":"The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality","volume":"129","author":"Hill","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2026011308563834500_bib29","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.bbmt.2020.04.028","article-title":"Hemorrhagic cystitis after haploidentical transplantation with post-transplantation cyclophosphamide: protective effect of MESNA continuous infusion","volume":"26","author":"Arango","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2026011308563834500_bib30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/tid.12455","article-title":"Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients","volume":"17","author":"Ruggeri","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"2026011308563834500_bib31","doi-asserted-by":"crossref","first-page":"e13101","DOI":"10.1111\/tid.13101","article-title":"Severe hemorrhagic cystitis caused by the BK polyomavirus is associated with decreased survival post-allogeneic hematopoietic stem cell transplantation","volume":"21","author":"Kerbauy","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"2026011308563834500_bib32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jpids\/piaa147","article-title":"BK virus epidemiology, risk factors, and clinical outcomes: an analysis of hematopoietic stem cell transplant patients at Texas Children\u2019s Hospital","volume":"10","author":"Ruderfer","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1","key":"2026011308563834500_bib33","first-page":"12","article-title":"ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients","volume":"73","author":"Cesaro","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"2026011308563834500_bib34","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.31557\/APJCP.2020.21.10.2877","article-title":"Prevalence of human polyomavirus JC and BK in normal population","volume":"21","author":"Karimi Dehcheshmeh","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"2026011308563834500_bib35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/ejh.14147","article-title":"Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy","volume":"112","author":"Galli","year":"2024","journal-title":"Eur J Haematol"},{"issue":"9","key":"2026011308563834500_bib36","doi-asserted-by":"crossref","first-page":"e13528","DOI":"10.1111\/ctr.13528","article-title":"BK polyomavirus in solid organ transplantation-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Hirsch","year":"2019","journal-title":"Clin Transplant"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/1\/1\/2478166\/blooda_adv-2025-016589-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/1\/1\/2478166\/blooda_adv-2025-016589-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:56:49Z","timestamp":1768312609000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/1\/1\/546898\/BK-virus-kinetics-and-associated-cystitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016589","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1,13]]},"published":{"date-parts":[[2025,12,29]]}}}